Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns ...Egypt

The US Food and Drug Administration granted accelerated approval Friday for the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. “Alzheimer’s disease immeasurably incapacitates the lives of those who suffer from it and has devastating effects on their loved ones,” Dr. Billy Dunn, director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research, said in a statement. “This treatment option is the latest therapy to target and affect the underlying disease process of Alzheimer’s, instead of only treating the symptoms of the disease.” Lecanemab will be marketed as Leqembi, the FDA st

Hence then, the article about alzheimer s drug lecanemab receives accelerated approval amid safety concerns was published today ( Monday 09/01/2023 - 12:04 PM ) and is available on EGYPT INDEPENDENT ( Egypt ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns )

Also on site :

• Here's How I Eat Gluten-Free at Disney World and Miss Nothing
• Has social justice become the new religion of the West?
• Ex-Ukrainian draft chief suspected of $1 million corruption